CVS Health Drug Trend Report Highlights Specialty Spending

In its 2020 Drug Trend Report, CVS Health Corp.’s Caremark PBM said its overall drug trend increased by 2.9% in 2020 and that 34% of its clients saw their pharmacy benefit spending decrease.

According to the report, specialty drug costs were the biggest concern. In fact, specialty treatments accounted for 52% of pharmacy spending in 2020, with 90% of spending concentrated on just five therapeutic categories. Despite that, the report asserts that “more than 40% of [Caremark] clients had single- digit specialty trend,” and “18% of [Caremark] clients had negative specialty trend.”

© 2022 MMIT
Peter Johnson

Peter Johnson

Peter has been a reporter for nearly a decade. Before joining AIS Health, Peter covered a wide variety of topics in his hometown of Seattle, where he continues to live. Peter’s work has appeared in publications including The Atlantic and The Stranger. Peter attended Colby College.

Related Posts

workers-prepping-infusion-drug
May 12

Major PBMs Look Ahead to 2023 for Biosimilars Boom

READ MORE
wall-street-sign
May 12

Centene Plans to Sell Magellan Rx, PANTHERx Rare for $2.8 Billion

READ MORE
pills-and-dollars
May 12

Study: With High Prices, Rebate Revenue Is Growing for PBMs

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today